STOCKWATCH
·
Misc Health and Biotechnology Services
Quarterly ResultMay 5, 2026, 05:07 PM

DaVita Q1 Revenue $3.42B, EPS $2.87; Acquires Elara Caring Minority Stake

AI Summary

DaVita Inc. reported strong financial results for the first quarter of 2026, with total revenues increasing by nearly 6% to $3.42 billion and diluted earnings per share rising by 43.5% to $2.87. Net income attributable to DaVita Inc. grew over 21% to $197.5 million. The company also announced a definitive agreement to acquire a noncontrolling minority interest in Elara Caring for approximately $200 million, expected to close mid-year 2026. Additionally, DaVita continued its share repurchase program, buying back 3.01 million shares for $402.86 million during the quarter, while facing ongoing legal proceedings.

Key Highlights

  • DaVita Q1 2026 total revenues increased 5.96% to $3.416 billion.
  • Diluted EPS rose 43.5% to $2.87 in Q1 2026 from $2.00 in Q1 2025.
  • Net income attributable to DaVita Inc. grew 21.25% to $197.53 million.
  • Agreed to acquire a noncontrolling minority interest in Elara Caring for approximately $200 million.
  • Repurchased 3.01 million shares for $402.86 million in Q1 2026.
  • Net cash provided by operating activities increased 78.23% to $320.83 million.
  • Long-term debt increased to $10.51 billion as of March 31, 2026.
DVA
Misc Health and Biotechnology Services
DAVITA INC.

Price Impact